Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03307759
Brief Title: Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma (SABRseq)

First Submitted : October 6, 2017
First Submitted that Met QC Criteria : October 11, 2017
First Posted : October 12, 2017

Last Update Submitted that Met QC Criteria : December 16, 2018
Last Update Posted : December 18, 2018 (Estimate)